StockFacets
About
Sign-up
Sign-in
Earnings Calendar
Prices are updated after-hours
Published
Previous years
2203
This month
4
This week
2
This year
52
Yesterday
2
Publishing Date
2022 - 06 - 13
12
2022 - 05 - 19
9
2022 - 05 - 03
9
2022 - 04 - 25
9
2022 - 03 - 01
11
2022 - 02 - 17
8
2022 - 02 - 15
9
2022 - 01 - 06
8
2022 - 01 - 04
9
2021 - 12 - 20
9
2021 - 12 - 14
8
2021 - 12 - 13
12
2021 - 12 - 10
8
2021 - 12 - 09
9
2021 - 12 - 01
8
2021 - 11 - 12
22
2021 - 11 - 11
8
2021 - 11 - 09
15
2021 - 11 - 08
8
2021 - 11 - 04
10
2021 - 11 - 02
10
2021 - 10 - 22
9
2021 - 10 - 21
14
2021 - 10 - 20
13
2021 - 10 - 19
8
2021 - 10 - 18
8
2021 - 10 - 14
8
2021 - 10 - 12
10
2021 - 10 - 07
8
2021 - 10 - 04
13
2021 - 10 - 01
26
2021 - 09 - 15
8
2021 - 09 - 09
10
2021 - 08 - 25
8
2021 - 07 - 19
9
2021 - 06 - 23
9
2021 - 06 - 22
8
2021 - 06 - 17
8
2021 - 06 - 10
13
2021 - 06 - 07
8
2021 - 06 - 04
11
2021 - 06 - 03
9
2021 - 05 - 12
9
2021 - 05 - 11
8
2021 - 05 - 10
8
2021 - 04 - 28
9
2021 - 04 - 27
14
2021 - 04 - 26
8
2021 - 04 - 20
9
2021 - 04 - 13
11
2021 - 04 - 12
8
2021 - 03 - 29
7
2021 - 03 - 23
7
2021 - 03 - 15
7
2021 - 03 - 08
7
2021 - 02 - 08
7
2021 - 01 - 19
13
2021 - 01 - 04
7
2020 - 12 - 21
7
2020 - 12 - 08
9
Sector
Commercial services
22
Communications
17
Consumer durables
5
Consumer non-durables
5
Consumer services
8
Distribution services
6
Electronic technology
18
Energy minerals
11
Finance
47
Finance and insurance
1
Health care and social assistance
2
Health services
45
Health technology
1816
Industrial services
1
Manufacturing
153
Mining, quarrying, and oil and gas extraction
1
Miscellaneous
4
N/a
17
Non-energy minerals
1
Process industries
6
Producer manufacturing
16
Professional, scientific, and technical services
53
Technology services
17
Transportation
1
Utilities
1
Tags
Acquisition
4305
Application
1790
Approval
1717
Awards
1452
Cancer
2848
Ceo
1679
Ces
4255
Collaboration
1772
Conference
15072
Contract
1515
Corporation
2482
Covid
2681
Covid-19
1837
Deadline
2038
Disease
1885
Distribution
2198
Drug
1974
Earnings
2867
Energy
4977
Europe
1759
Ev
1455
Events
3833
Fda
2332
Financial
2778
Financial results
8251
For
13565
Global
4033
Group
2301
Growth
8021
Health
3372
Iot
1743
Market
11524
Media
1482
N/a
176026
Nasdaq
1902
Offering
5420
Partnership
1821
People
2022
Pharm-country
1505
Pharma
1551
Phase 2
1768
Platform
1424
Positive
2072
Presentation
2341
Program
2357
Report
8415
Research
7264
Results
26646
Sales
1571
Services
1463
System
1722
Technology
4173
Test
2090
Therapeutics
4949
Therapy
2203
Treatment
3641
Trial
5145
Update
1553
Vaccine
1621
Year
1470
Entities
Abbott laboratories
12
Abbvie inc.
29
Abeona therapeutics inc.
13
Accuray incorporated
18
Allogene therapeutics, inc.
11
Amgen inc.
30
Anixa biosciences, inc.
14
Applied genetic technologies corporation
13
Astrazeneca plc
20
Ati physical therapy inc - class a
29
Avrobio, inc.
20
Baxter international inc.
12
Beyondspring, inc.
11
Biocardia, inc.
16
Biocryst pharmaceuticals, inc.
14
Biogen inc.
16
Biomarin pharmaceutical inc.
23
Biorestorative therapies, inc.
18
Bluebird bio, inc.
27
Brainsway ltd.
15
Bridgebio pharma, inc.
14
Bristol-myers squibb company
53
Celularity inc - class a
13
Compass pathways plc
12
Crispr therapeutics ag
13
Eli lilly and company
66
Fate therapeutics, inc.
15
Fortress value acquisition corp.
22
Fortress value acquisition corp. ii
22
Gamida cell ltd.
13
Genprex, inc.
13
Gilead sciences, inc.
39
Glaxosmithkline plc
18
Incyte corporation
27
Intellia therapeutics, inc.
15
Intra-cellular therapies inc.
32
Iovance biotherapeutics, inc.
13
Jaguar health, inc.
14
Johnson & johnson
68
Medtronic plc
21
Merck & company, inc.
27
Neuronetics, inc.
26
Novartis ag
61
Orange
16
Orchard therapeutics plc
14
Pfizer, inc.
26
Poseida therapeutics, inc.
18
Regeneron pharmaceuticals, inc.
13
Regenxbio inc.
16
Sanofi
82
Sarepta therapeutics, inc.
19
Sio gene therapies inc
25
Takeda pharmaceutical company limited
30
Taysha gene therapies, inc.
48
Thermo fisher scientific inc
18
Ultragenyx pharmaceutical inc.
12
Uniqure n.v.
26
Varian medical systems, inc.
16
Vericel corporation
12
Viewray, inc.
30
Symbols
ABBV
29
ABEO
13
ABT
12
AGTC
13
AMGN
30
ANIX
14
ARAY
18
ATIP
29
AVRO
20
AZN
20
AZNCF
14
BAX
12
BBIO
14
BCDA
16
BCRX
14
BIIB
16
BLUE
27
BMRN
23
BMY
53
BRTX
16
BRTXD
18
BWAY
15
CELU
13
CMPS
12
CRSP
13
FAII
22
FATE
15
FNCTF
16
FVAC
22
GILD
39
GMDA
13
GNPX
13
GSK
18
INCY
27
IOVA
13
ITCI
32
JAGX
14
JNJ
68
LLY
66
MDT
21
MRK
27
NTLA
15
NVS
61
NVSEF
36
ORTX
14
PFE
26
PSTX
18
QURE
26
REGN
13
RGNX
16
SIOX
25
SNY
82
SNYNF
48
SRPT
19
STIM
26
TAK
30
TMO
18
TSHA
48
VAR
16
VRAY
30
Exchanges
Amex
51
Lse
22
Nasdaq
1841
Nyse
502
Tsx
5
Crawled Date
2022 - 06 - 13
12
2022 - 05 - 19
9
2022 - 04 - 25
9
2022 - 03 - 01
10
2022 - 02 - 17
8
2022 - 02 - 15
9
2022 - 01 - 06
8
2022 - 01 - 04
8
2021 - 12 - 20
10
2021 - 12 - 14
8
2021 - 12 - 13
12
2021 - 12 - 09
9
2021 - 12 - 01
8
2021 - 11 - 12
21
2021 - 11 - 11
8
2021 - 11 - 09
14
2021 - 11 - 08
8
2021 - 11 - 04
9
2021 - 11 - 02
10
2021 - 10 - 22
9
2021 - 10 - 21
14
2021 - 10 - 20
13
2021 - 10 - 19
10
2021 - 10 - 12
11
2021 - 10 - 07
8
2021 - 10 - 04
13
2021 - 10 - 01
26
2021 - 09 - 15
8
2021 - 09 - 09
10
2021 - 07 - 19
9
2021 - 06 - 23
9
2021 - 06 - 22
8
2021 - 06 - 17
8
2021 - 06 - 11
8
2021 - 06 - 10
12
2021 - 06 - 07
8
2021 - 06 - 04
11
2021 - 06 - 03
9
2021 - 05 - 14
7
2021 - 05 - 12
9
2021 - 05 - 11
8
2021 - 05 - 10
8
2021 - 05 - 04
7
2021 - 04 - 28
9
2021 - 04 - 27
13
2021 - 04 - 26
8
2021 - 04 - 20
9
2021 - 04 - 13
10
2021 - 04 - 12
8
2021 - 03 - 29
8
2021 - 03 - 23
7
2021 - 03 - 08
7
2021 - 02 - 08
7
2021 - 01 - 19
13
2021 - 01 - 04
8
2020 - 12 - 21
7
2020 - 12 - 15
7
2020 - 12 - 08
9
2020 - 12 - 02
7
2020 - 12 - 01
9
Crawled Time
00:00
33
00:20
7
01:00
35
02:00
16
03:00
3
04:00
2
04:20
5
05:00
7
06:00
10
07:00
25
08:00
22
09:00
28
10:00
23
10:18
2
11:00
83
11:33
2
12:00
322
12:01
5
12:03
12
12:05
2
12:15
53
12:20
35
12:30
36
13:00
192
13:01
5
13:02
5
13:03
18
13:05
3
13:15
40
13:20
41
13:30
32
14:00
184
14:01
5
14:02
3
14:03
4
14:15
29
14:20
23
14:30
25
14:47
3
15:00
113
15:01
3
15:15
14
15:20
16
15:30
13
16:00
87
16:15
6
16:20
24
17:00
81
17:20
3
18:00
65
19:00
63
19:01
3
20:00
46
20:20
5
21:00
87
21:03
5
22:00
69
22:04
3
22:15
5
23:00
53
Source
feed.businesswire.com
3
investor.alkermes.com
2
investor.aveooncology.com
1
investors.biomarin.com
10
investors.phiopharma.com
1
investors.senseibio.com
1
ir.akerotx.com
3
ir.biolinerx.com
1
ir.catabasis.com
1
ir.hoththerapeutics.com
1
ir.kalvista.com
2
ir.plxpharma.com
2
ir.pulmatrix.com
2
ir.therapeuticsmd.com
1
ir.vaccinex.com
1
ir.voyagertherapeutics.com
2
ir.vtvtherapeutics.com
3
jaguarhealth.gcs-web.com
9
neurosense.investorroom.com
1
ocutx.gcs-web.com
1
renovorx.com
7
spacfeed.com
1
www.adnas.com
1
www.affimed.com
1
www.allogene.com
3
www.avrobio.com
5
www.beyondspringpharma.com
4
www.biospace.com
1111
www.brainsway.com
13
www.celyad.com
2
www.clarivate.com
1
www.clinuvel.com
1
www.cuebiopharma.com
1
www.eksobionics.com
1
www.electromed.com
3
www.fatetherapeutics.com
10
www.fda.gov
5
www.globenewswire.com
521
www.halozyme.com
1
www.igmbio.com
3
www.immatics.com
3
www.immunic-therapeutics.com
3
www.immunogen.com
1
www.immunoprecise.com
1
www.inovio.com
1
www.lhcgroup.com
2
www.middleby.com
2
www.nantkwest.com
7
www.nhccare.com
2
www.novocure.com
1
www.orthofix.com
1
www.poseida.com
6
www.prnewswire.com
417
www.progyny.com
1
www.thermogenesis.com
11
www.vbivaccines.com
1
Sort by:
after hours % change
|
delayed % change
|
gain open
|
gain high
|
gain close
|
publishing date
(GMT-12:00) International Date Line West
(GMT-11:00) American Samoa
(GMT-11:00) Midway Island
(GMT-10:00) Hawaii
(GMT-09:00) Alaska
(GMT-08:00) Pacific Time (US & Canada)
(GMT-08:00) Tijuana
(GMT-07:00) Arizona
(GMT-07:00) Chihuahua
(GMT-07:00) Mazatlan
(GMT-07:00) Mountain Time (US & Canada)
(GMT-06:00) Central America
(GMT-06:00) Central Time (US & Canada)
(GMT-06:00) Guadalajara
(GMT-06:00) Mexico City
(GMT-06:00) Monterrey
(GMT-06:00) Saskatchewan
(GMT-05:00) Bogota
(GMT-05:00) Eastern Time (US & Canada)
(GMT-05:00) Indiana (East)
(GMT-05:00) Lima
(GMT-05:00) Quito
(GMT-04:00) Atlantic Time (Canada)
(GMT-04:00) Caracas
(GMT-04:00) Georgetown
(GMT-04:00) La Paz
(GMT-04:00) Puerto Rico
(GMT-04:00) Santiago
(GMT-03:30) Newfoundland
(GMT-03:00) Brasilia
(GMT-03:00) Buenos Aires
(GMT-03:00) Greenland
(GMT-03:00) Montevideo
(GMT-02:00) Mid-Atlantic
(GMT-01:00) Azores
(GMT-01:00) Cape Verde Is.
(GMT+00:00) Casablanca
(GMT+00:00) Dublin
(GMT+00:00) Edinburgh
(GMT+00:00) Lisbon
(GMT+00:00) London
(GMT+00:00) Monrovia
(GMT+00:00) UTC
(GMT+01:00) Amsterdam
(GMT+01:00) Belgrade
(GMT+01:00) Berlin
(GMT+01:00) Bern
(GMT+01:00) Bratislava
(GMT+01:00) Brussels
(GMT+01:00) Budapest
(GMT+01:00) Copenhagen
(GMT+01:00) Ljubljana
(GMT+01:00) Madrid
(GMT+01:00) Paris
(GMT+01:00) Prague
(GMT+01:00) Rome
(GMT+01:00) Sarajevo
(GMT+01:00) Skopje
(GMT+01:00) Stockholm
(GMT+01:00) Vienna
(GMT+01:00) Warsaw
(GMT+01:00) West Central Africa
(GMT+01:00) Zagreb
(GMT+01:00) Zurich
(GMT+02:00) Athens
(GMT+02:00) Bucharest
(GMT+02:00) Cairo
(GMT+02:00) Harare
(GMT+02:00) Helsinki
(GMT+02:00) Jerusalem
(GMT+02:00) Kaliningrad
(GMT+02:00) Kyiv
(GMT+02:00) Pretoria
(GMT+02:00) Riga
(GMT+02:00) Sofia
(GMT+02:00) Tallinn
(GMT+02:00) Vilnius
(GMT+03:00) Baghdad
(GMT+03:00) Istanbul
(GMT+03:00) Kuwait
(GMT+03:00) Minsk
(GMT+03:00) Moscow
(GMT+03:00) Nairobi
(GMT+03:00) Riyadh
(GMT+03:00) St. Petersburg
(GMT+03:30) Tehran
(GMT+04:00) Abu Dhabi
(GMT+04:00) Baku
(GMT+04:00) Muscat
(GMT+04:00) Samara
(GMT+04:00) Tbilisi
(GMT+04:00) Volgograd
(GMT+04:00) Yerevan
(GMT+04:30) Kabul
(GMT+05:00) Ekaterinburg
(GMT+05:00) Islamabad
(GMT+05:00) Karachi
(GMT+05:00) Tashkent
(GMT+05:30) Chennai
(GMT+05:30) Kolkata
(GMT+05:30) Mumbai
(GMT+05:30) New Delhi
(GMT+05:30) Sri Jayawardenepura
(GMT+05:45) Kathmandu
(GMT+06:00) Almaty
(GMT+06:00) Astana
(GMT+06:00) Dhaka
(GMT+06:00) Urumqi
(GMT+06:30) Rangoon
(GMT+07:00) Bangkok
(GMT+07:00) Hanoi
(GMT+07:00) Jakarta
(GMT+07:00) Krasnoyarsk
(GMT+07:00) Novosibirsk
(GMT+08:00) Beijing
(GMT+08:00) Chongqing
(GMT+08:00) Hong Kong
(GMT+08:00) Irkutsk
(GMT+08:00) Kuala Lumpur
(GMT+08:00) Perth
(GMT+08:00) Singapore
(GMT+08:00) Taipei
(GMT+08:00) Ulaanbaatar
(GMT+09:00) Osaka
(GMT+09:00) Sapporo
(GMT+09:00) Seoul
(GMT+09:00) Tokyo
(GMT+09:00) Yakutsk
(GMT+09:30) Adelaide
(GMT+09:30) Darwin
(GMT+10:00) Brisbane
(GMT+10:00) Canberra
(GMT+10:00) Guam
(GMT+10:00) Hobart
(GMT+10:00) Melbourne
(GMT+10:00) Port Moresby
(GMT+10:00) Sydney
(GMT+10:00) Vladivostok
(GMT+11:00) Magadan
(GMT+11:00) New Caledonia
(GMT+11:00) Solomon Is.
(GMT+11:00) Srednekolymsk
(GMT+12:00) Auckland
(GMT+12:00) Fiji
(GMT+12:00) Kamchatka
(GMT+12:00) Marshall Is.
(GMT+12:00) Wellington
(GMT+12:45) Chatham Is.
(GMT+13:00) Nuku'alofa
(GMT+13:00) Samoa
(GMT+13:00) Tokelau Is.
tags :
Therapy
save search
Exact Sciences Launches OncoExTra™ Cancer Therapy Selection Test in the U.S.
Published:
2023-02-07
(Crawled : 16:00)
- biospace.com/
EXAS
|
$68.2
-0.54%
500K
|
Health Technology
|
-0.21%
|
O:
-0.21%
H:
0.0%
C:
0.0%
sciences
test
therapy
cancer
Rocket Pharmaceuticals Receives FDA Regenerative Medicine Advanced Therapy (RMAT) Designation for RP-A501 Gene Therapy for Danon Disease
Published:
2023-02-07
(Crawled : 13:00)
- biospace.com/
RCKT
|
$20.14
-4.1%
190K
|
Health Technology
|
-0.39%
|
O:
-0.39%
H:
0.0%
C:
0.0%
fda
pharmaceuticals
designation
disease
for
therapy
rp-a501
rmat
danon disease
Merck’s KEYTRUDA® (pembrolizumab) Plus Chemotherapy Met Primary Endpoint of Progression-Free Survival (PFS) as First-Line Therapy for Advanced or Recurrent Endometrial Carcinoma
Published:
2023-02-03
(Crawled : 14:20)
- biospace.com/
MRK
S
|
$106.95
1.2%
2.9M
|
Health Technology
|
0.55%
|
O:
-0.31%
H:
0.0%
C:
0.0%
keytruda
for
plus
therapy
Verastem Oncology Outlines Key 2023 Strategic Priorities and Upcoming Catalysts for Advancing Avutometinib as a Backbone of Therapy for RAS Pathway-Driven Cancers
Published:
2023-02-02
(Crawled : 13:00)
- biospace.com/
VSTM
|
$0.6862
-0.55%
490K
|
Health Technology
|
7.89%
|
O:
5.61%
H:
7.11%
C:
4.14%
cancer
therapy
avutometinib
ras pathway
defactinib
lgsoc program
vs-6766
uniQure and Apic Bio enter into global licensing agreement for APB-102, a clinical stage gene therapy for patients with ALS caused by mutations in SOD1
Published:
2023-01-31
(Crawled : 13:00)
- biospace.com/
QURE
|
$22.24
-2.97%
62K
|
Health Technology
|
8.6%
|
O:
0.97%
H:
2.92%
C:
1.72%
apb-102
global
for
als
agreement
therapy
Autologous Cell Therapy Market Report 2022: Sector to Reach $24.31 Billion by 2030 at a 19.4% CAGR
Published:
2023-01-30
(Crawled : 19:00)
- prnewswire.com
GLW
|
News
|
$35.32
0.37%
1.8M
|
Electronic Technology
|
-4.88%
|
O:
-0.74%
H:
0.0%
C:
-4.89%
VCEL
|
$29.66
-4.75%
70K
|
Health Technology
|
8.38%
|
O:
-4.27%
H:
1.89%
C:
1.63%
report
therapy
market
Moderna Granted FDA Breakthrough Therapy Designation for mRNA-1345, An Investigational Respiratory Syncytial Virus (RSV) Vaccine Candidate
Published:
2023-01-30
(Crawled : 13:00)
- biospace.com/
MRNA
M
|
$165.25
-3.4%
1.4M
|
Health Technology
|
-11.1%
|
O:
-2.73%
H:
0.0%
C:
0.0%
rna-1345
fda
designation
candidate
for
vaccine
respiratory
virus
granted
therapy
Cell & Gene Therapy Manufacturing Services Market worth $11.5 billion by 2027 - Exclusive Report by MarketsandMarkets™
Published:
2023-01-27
(Crawled : 15:20)
- prnewswire.com
NINOY
|
$9.48
0
|
Manufacturing
|
Email alert
Add to watchlist
NINOF
|
$9.37
0
|
Consumer Durables
|
Email alert
Add to watchlist
services
report
therapy
market
Sana Biotechnology Announces FDA Clearance of Investigational New Drug Application for SC291, a Hypoimmune-modified, CD19-targeted Allogeneic CAR T Therapy for Patients with B-Cell Malignancies
Published:
2023-01-26
(Crawled : 23:00)
- biospace.com/
SANA
|
$4.505
-5.36%
160K
|
|
0.21%
|
O:
1.06%
H:
1.05%
C:
-3.15%
sc291
fda
clearance
drug
for
application
therapy
Cell Therapy Global Market Report 2022: Sector to Expand by 14.8% Annually Through 2033
Published:
2023-01-26
(Crawled : 19:00)
- prnewswire.com
VCEL
|
$29.66
-4.75%
70K
|
Health Technology
|
Email alert
Add to watchlist
global
report
therapy
market
Daré Bioscience Announces Publication in Menopause: The Journal of The North American Menopause Society of Data from Phase 1 Trial of DARE-HRT1 that Support the Potential of DARE-HRT1 as an Effective Hormone Therapy for both Vasomotor and Vaginal Symptoms of Menopause
Published:
2023-01-26
(Crawled : 14:00)
- globenewswire.com
DARE
|
$1.235
2.92%
130K
|
Health Technology
|
6.49%
|
O:
18.61%
H:
2.19%
C:
-0.73%
for
trial
potential
therapy
bioscience
publication
hormone
CareCloud to Unveil Innovative EHR Therapy Platform at American Physical Therapy Association Meeting
Published:
2023-01-26
(Crawled : 14:00)
- globenewswire.com
CCLD
new
|
$3.42
6.8K
|
Manufacturing
|
-9.16%
|
O:
0.0%
H:
0.0%
C:
-1.35%
meeting
association
therapy
platform
Pathway Development Consortium Announces Publication in Human Gene Therapy on the Application of FDA’s Accelerated Approval Pathway for AAV Gene Therapies for Patients with Duchenne Muscular Dystrophy
Published:
2023-01-26
(Crawled : 14:00)
- globenewswire.com
SLDB
|
News
M
|
$7.72
-0.52%
4.3K
|
Health Technology
|
7.26%
|
O:
2.83%
H:
0.94%
C:
0.13%
RGNX
|
News
|
$23.435
-2.44%
85K
|
Health Technology
|
0.0%
|
O:
-0.43%
H:
0.63%
C:
-0.69%
for
application
approval
duchenne
therapy
publication
Scripps Health Radiation Therapy Centers Named Patient Safety Center of Excellence by Sun Nuclear
Published:
2023-01-26
(Crawled : 13:20)
- prnewswire.com
MIR
|
News
|
$7.96
-1.85%
530K
|
|
6.06%
|
O:
2.09%
H:
1.28%
C:
0.64%
LEA
|
$140.63
-0.6%
190K
|
Producer Manufacturing
|
5.62%
|
O:
2.8%
H:
0.25%
C:
-0.34%
health
nuclear
therapy
Hoth Therapeutics Announces Selection of First 3 Clinical Sites for its Phase 2 Clinical Trial to Treat Cancer Disorders Associated with Epidermal Growth Factor Receptor (EGFR) Inhibitor Therapy
Published:
2023-01-25
(Crawled : 15:20)
- biospace.com/
HOTH
|
News
|
$3.95
-8.14%
6.8M
|
Health Technology
|
-10.0%
|
O:
0.78%
H:
0.0%
C:
0.0%
for
trial
therapeutics
therapy
cancer
growth
Merck Announces KEYNOTE-991 Trial Evaluating KEYTRUDA® (pembrolizumab) Plus Enzalutamide and Androgen Deprivation Therapy in Patients With Metastatic Hormone-Sensitive Prostate Cancer to Stop for Futility
Published:
2023-01-25
(Crawled : 12:00)
- biospace.com/
MRK
S
|
$106.95
1.2%
2.9M
|
Health Technology
|
-5.0%
|
O:
-0.56%
H:
0.0%
C:
0.0%
ynote-991
keytruda
for
trial
plus
therapy
cancer
Decibel Therapeutics Announces Approval of Clinical Trial Application by the U.K. Medicines and Healthcare Products Regulatory Agency for Lead Gene Therapy Candidate DB-OTO
Published:
2023-01-24
(Crawled : 13:20)
- biospace.com/
DBTX
|
$4.17
16.16%
210K
|
Health Technology
|
34.6%
|
O:
7.82%
H:
18.49%
C:
15.32%
REGN
M
|
$756.62
-1.73%
180K
|
Health Technology
|
8.47%
|
O:
1.55%
H:
0.18%
C:
-0.48%
candidate
for
application
trial
approval
therapeutics
therapy
Compression Therapy Market Size to Reach USD 4.77 Billion in 2030 | Emergen Research
Published:
2023-01-23
(Crawled : 18:00)
- prnewswire.com
MMSI
|
$71.36
-0.35%
32K
|
Health Technology
|
Email alert
Add to watchlist
research
therapy
market
REGENXBIO Announces Phase I/II Trial of RGX-202, a Novel Gene Therapy Candidate for Duchenne Muscular Dystrophy, is Active and Recruiting Patients
Published:
2023-01-23
(Crawled : 13:00)
- biospace.com/
RGNX
|
News
|
$23.435
-2.44%
85K
|
Health Technology
|
1.79%
|
O:
-0.88%
H:
1.37%
C:
0.09%
rgx-202
candidate
active
for
trial
duchenne
therapy
Market Forecasts for Immuno-Oncology Diagnostics 2023: Sector Represents a Revolution in Cancer Therapy
Published:
2023-01-20
(Crawled : 22:00)
- prnewswire.com
ABT
|
$110.4
-1.42%
1.3M
|
Health Technology
|
Email alert
Add to watchlist
ANPCY
|
$3.545
0
|
Manufacturing
|
Email alert
Add to watchlist
BIO
|
$471.46
-1.15%
20K
|
Health Technology
|
Email alert
Add to watchlist
TXG
|
$46.53
-3.7%
300K
|
Health Technology
|
Email alert
Add to watchlist
MDLS
|
$
0%
|
n/a
|
Email alert
Add to watchlist
NVTA
|
$2.39
-3.63%
5.4M
|
Health Services
|
Email alert
Add to watchlist
TMO
|
$582.1
-0.18%
430K
|
Health Technology
|
Email alert
Add to watchlist
BDX
S
|
$250.455
-1.08%
340K
|
Health Technology
|
Email alert
Add to watchlist
ANPCF
|
$0.52
|
Health Technology
|
Email alert
Add to watchlist
CSTL
S
|
$26.845
0.09%
53K
|
Health Technology
|
Email alert
Add to watchlist
ICLR
|
$239.76
-0.89%
130K
|
Health Technology
|
Email alert
Add to watchlist
BIOC
|
$0.514
45K
|
Health Services
|
Email alert
Add to watchlist
NH
|
$3.9
4.5%
4.8K
|
Technology Services
|
Email alert
Add to watchlist
MLAB
G
|
$181.51
-0.95%
25K
|
Health Technology
|
Email alert
Add to watchlist
for
diagnostics
therapy
cancer
market
← Previous
1
2
3
4
5
6
7
8
9
…
110
111
Next →
Gainers vs Losers
52%
48%
Top 10 Gainers
DGLY
|
News
|
$5.43
1722.15%
150K
|
Electronic Technology
CELZ
|
$1.11
114.58%
120M
|
GFAI
|
$0.481
40.85%
60M
|
KPRX
|
News
|
$6.17
35.6%
14M
|
Manufacturing
PRFX
|
$0.65
30.0%
13M
|
Health Technology
WETG
|
$0.514
25.37%
11M
|
AVRO
|
$1.07
22.64%
540K
|
Health Technology
BBLG
|
$0.3799
20.76%
740K
|
n/a
MSGM
P
2 d
|
$15.78
19.73%
5.1M
|
THCH
|
$4.995
18.93%
550K
|
n/a
Your saved searches
Save your searches and get alerts when important news are released.